Zakłady Farmaceutyczne Polpharma S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-08-22
Share capital
101,015,400.00 PLN
Activity description

Zakłady Farmaceutyczne Polpharma is the largest Polish manufacturer of pharmaceuticals and active pharmaceutical ingredients. The company actively operates in the markets of Central and Eastern Europe, the Caucasus, and Central Asia.

Registered address
Pelplińska 19, 83-200 Starogard Gdański, Poland
Branches
  • ul. Metalowca 2, 39-460 Nowa Dęba
  • ul. Władysława Łokietka 10, 98-200 Sieradz
  • ul. Bobrowiecka 6, 00-728 Warszawa
  • ul. Ożarowska 28/30, 05-850 Ożarów Mazowiecki
Email
Social media
Electronic delivery address
AE:PL-25050-41533-IEJTA-23

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 44 days early. All were audited by a statutory auditor.

  • 202514/05/2026
  • 202414/05/2025
  • 202308/07/2024
  • 202229/06/2023
  • 202107/07/2022
  • 202028/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing25 / 24,548
Top <1%
City · Starogard Gdański1 / 194
Top <1%
Voivodeship · Pomorskie5 / 20,062
Top <1%
Country · Poland126 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 1.36bnMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD 278.06mMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 975.05mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 1.40bnMedianUSD 897.46kAverageUSD 31.52m

Offer

  • Medicines
  • Pharmaceutical substances
  • Pharmaceutical products

Websites

The company has 12 websites. The sites are available in: Polish and English. The company measures traffic with Google Analytics and uses the Meta advertising pixel (Facebook, Instagram).

  • polpharma.plStrona główna – Polpharma
    WordPressGoogle AnalyticsGoogle Tag ManagerYoast SEOApache
  • acidolac.plAcidolac | Suplement diety | Przyjaciel dziecięcych brzuszków
    WordPressYoast SEOApache
  • allertec.plAllertec® Effect – na objawy alergii
    WebflowGoogle Tag ManagerCloudflare

Public procurement

25 tenders recorded as contracting authority.

Notices (contracting authority)

SubjectAmount
Poland-Starogard Gdański: Biomedical equipment
–
Poland-Starogard Gdański: Laboratory, optical and precision equipment (except glass)
–
Poland-Starogard Gdański: Laboratory, optical and precision equipment (except glass)
–

Trademarks

The company currently holds no active trademarks with the Polish Patent Office. 293 marks have expired or were not registered. The first mark was filed in 1987.

MarkNumberClassesStatusProtected until
Sonidex Z.4017995Expired –
LAZUREX Z.4017985Expired –
Moxiten Z.3921835Expired –
Optilamid Z.3919875Expired –
Glitecur Z.3919865Expired –
MarkProtected until
Sonidex –
LAZUREX –
Moxiten –
Optilamid –
Glitecur –

Job offers

The company has its own careers page: polpharma.pl/praca-w-polpharmie.

Authorized Representatives

Agnieszka Jolanta Deeg-Tyburska age 58 – Management Board Member
Andrzej Dziuban age 51 – Management Board Member
Marcin Wiesław Bruchmann age 50 – Management Board Member
Dorota Małgorzata Chęć age 51 – Management Board Member
Robert Erich Knerr – Management Board Member

Manner of representation

Joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will and sign on behalf of the company.

Supervisory board

Martyna Agnieszka Smentek age 50 – Supervisory Board Member
Piotr Bukowski age 54 – Supervisory Board Member
Gabriel Wujek age 74 – Supervisory Board Member
Jakub Jan Gomuła age 51 – Supervisory Board Member
Nicholas Haggar – Supervisory Board Member

Ownership

Owner
Polpharma Group Holding B.v.

Beneficial owners

Person

Capital group

The company is the parent company of a corporate group.

NameOwnership
100%
Polpharma Biuro Hanlowe Sp. z o.o.
100%
100%

Bank accounts

Registered as a VAT taxpayer on 1993-07-05.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

12 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
Sep 30, 2026Bankruptcy notice
Feb 1, 2024Merger registered
Jan 12, 2024Merger registered
Apr 27, 2021Merger registered
Jan 18, 2021Shareholders' meeting convened

Public aid

48 public aid cases recorded, with a total value of $202,480,103.

PurposeGross amount
Regional investment aid
–
Regional investment aid
–
Aid for research and development projects: experimental development
–

European Funds

7 projects co-financed from European Funds recorded, with total EU co-financing of $22,474,941.

ProjectEU co-financing
Development of an innovative technological and analytical platform for the production of medicines containing oligonucleotides in ready-to-use form.
$7.7M
Development and advancement of an innovative solution – a complex, two-component medicinal product targeting the treatment of hypertension
$2.5M
Development of a tool using artificial intelligence algorithms to forecast sales volumes and plan marketing strategies for pharmaceutical products
$2.6M

Regulatory authorisations

AuthorityTypeStatus
Integrated permit Active

Competitors

Name
Adamed Pharma S.A.
Teva Operations Poland sp. z o.o.
Fresenius Kabi Polska sp. z o.o.
Delpharm Poznań S.A.
Tarchomińskie Zakłady Farmaceutyczne Polfa S.A.
Natur Produkt Pharma sp. z o.o.
ICN Polfa Rzeszów S.A.
Celon Pharma S.A.
Wörwag Pharma Operations sp. z o.o.
Phytopharm Klęka S.A.

Change history

DateEvent
2026-09-30Share capital increase
2009-07-10Share capital reduction
2007-11-15Share capital reduction
2004-01-27Share capital increase
2002-08-22Entered in the register

FAQ

Last updated: 2026-10-07